Results 141 to 150 of about 5,801 (166)

Molnupiravir

2021
openaire   +1 more source

Transfer and biotransformation of the COVID-19 prodrug molnupiravir and its metabolite β-D-N4-hydroxycytidine across the blood-placenta barrier

EBioMedicine, 2023
Jeffrey Dalley, Tung-Hu Tsai, Wen-Ya Peng   +2 more
exaly  

Development of a Robust Manufacturing Route for Molnupiravir, an Antiviral for the Treatment of COVID-19

Organic Process Research and Development, 2021
Guy Humphrey, Khateeta Emerson, Rachel Bade   +2 more
exaly  

Molnupiravir for Covid-19 in Nonhospitalized Patients

New England Journal of Medicine, 2022
Kristian, Thorlund, Kyle, Sheldrick, Edward, Mills   +2 more
openaire   +5 more sources

Molnupiravir: A new candidate for COVID‐19 treatment

Pharmacology Research and Perspectives, 2022
Fariba Pourkarim, Haleh Rezaee
exaly  

Concise Synthesis of Molnupiravir

Synfacts, 2021
openaire   +1 more source

Antiviral Efficacy of Molnupiravir for COVID-19 Treatment

Viruses, 2022
Mingwang Shen, Bai Yuan, Shen Mingwang   +2 more
exaly  

A stability indicating RP-HPLC method for determination of the COVID-19 drug molnupiravir applied using nanoformulations in permeability studies

Journal of Pharmaceutical and Biomedical Analysis, 2022
Håkan Eroglu, Tuba REÇBER, Selin Seda Timur   +2 more
exaly  

PROCESS FOR THE PREPARATION OF MOLNUPIRAVIR

2022
DIVI MURALI KRISHNA PRASAD, RAO MYSORE ASWATHANARAYANA   +1 more
openaire   +3 more sources

Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry

International Journal of Antimicrobial Agents, 2023
Iker Falces-Romero, Francesco Marchesi, Oliver A Cornely   +2 more
exaly